AU7711096A - Cisplatinum comprising pharmaceutical - Google Patents

Cisplatinum comprising pharmaceutical

Info

Publication number
AU7711096A
AU7711096A AU77110/96A AU7711096A AU7711096A AU 7711096 A AU7711096 A AU 7711096A AU 77110/96 A AU77110/96 A AU 77110/96A AU 7711096 A AU7711096 A AU 7711096A AU 7711096 A AU7711096 A AU 7711096A
Authority
AU
Australia
Prior art keywords
cisplatinum
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77110/96A
Inventor
Ben De Kruijff
Jan Reedijk
Gelske Speelmans
Rutger Willibrordus Hendricus Maria Staffhorst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Utrecht
Original Assignee
Universiteit Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Utrecht filed Critical Universiteit Utrecht
Publication of AU7711096A publication Critical patent/AU7711096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU77110/96A 1996-12-03 1996-12-03 Cisplatinum comprising pharmaceutical Abandoned AU7711096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL1996/000474 WO1998024424A1 (en) 1996-12-03 1996-12-03 Cisplatinum comprising pharmaceutical

Publications (1)

Publication Number Publication Date
AU7711096A true AU7711096A (en) 1998-06-29

Family

ID=19866012

Family Applications (2)

Application Number Title Priority Date Filing Date
AU77110/96A Abandoned AU7711096A (en) 1996-12-03 1996-12-03 Cisplatinum comprising pharmaceutical
AU54168/98A Abandoned AU5416898A (en) 1996-12-03 1997-12-03 Cisplatinum comprising pharmaceutical

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU54168/98A Abandoned AU5416898A (en) 1996-12-03 1997-12-03 Cisplatinum comprising pharmaceutical

Country Status (2)

Country Link
AU (2) AU7711096A (en)
WO (2) WO1998024424A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
WO2004054499A2 (en) * 2002-08-02 2004-07-01 Transave, Inc. Platinum aggregates and process for producing the same
AU2004235781A1 (en) * 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Lipid platinum complexes and methods of use thereof
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
EP2892524B1 (en) 2012-09-04 2020-11-25 Eleison Pharmaceuticals, LLC Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
SG11201610306RA (en) 2014-06-11 2017-01-27 Univ Texas Texaphyrin-pt(iv) conjugates and compositions for use in overcoming platinum resistance
CN109745338B (en) * 2019-01-17 2021-03-30 南开大学 Preparation method and application of Pt (IV) polymer prodrug micelle encapsulating vorinostat and having reduction response

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
JP4107680B2 (en) * 1994-11-18 2008-06-25 アフィオス・コーポレーション Method for producing liposomes containing a hydrophobic drug

Also Published As

Publication number Publication date
WO1998024425A1 (en) 1998-06-11
WO1998024424A1 (en) 1998-06-11
AU5416898A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU6740298A (en) Pharmaceutical composition
AU5387898A (en) Pharmaceutical agents
AU8495998A (en) Improved dosage units
AU1409100A (en) Drugs
GB9715490D0 (en) Pharmaceutical preparation
AU8591898A (en) Pharmaceutical compounds
GB9408053D0 (en) Pharmaceutical preparation
AU4330097A (en) Pharmaceutical compounds
AU2531295A (en) Pharmaceutical composition
ZA982073B (en) Pharmaceutical preparation
AU9343098A (en) Pharmaceutical composition
AU5416898A (en) Cisplatinum comprising pharmaceutical
AU4169897A (en) Pharmaceutical compounds
AU1475595A (en) Pharmaceutical preparation
GB9709739D0 (en) Pharmaceutical formulation
AU1688099A (en) Pharmaceutical preparation
AP9801196A0 (en) Pharmaceutical preparation
AU5182099A (en) Pharmaceutical formulation
AU2279800A (en) Pharmaceutical preparation
AU2043295A (en) Antiulcer drug
AU5049098A (en) Pharmaceutical formulation
AUPP574298A0 (en) Pharmaceutical preparation
AU4948297A (en) Pharmaceutical preparation